Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

586 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The pre-thrombotic state.
Davies JA. Davies JA. Clin Sci (Lond). 1985 Dec;69(6):641-6. doi: 10.1042/cs0690641. Clin Sci (Lond). 1985. PMID: 3905216 Review. No abstract available.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 May 16:S0140-6736(24)00548-8. doi: 10.1016/S0140-6736(24)00548-8. Online ahead of print. Lancet. 2024. PMID: 38763154 Free article.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Parker CC, Kynaston H, Cook AD, Clarke NW, Catton CN, Cross WR, Petersen PM, Persad RA, Pugh CA, Saad F, Logue J, Payne H, Bower LC, Brawley C, Rauchenberger M, Barkati M, Bottomley DM, Brasso K, Chung HT, Chung PWM, Conroy R, Falconer A, Ford V, Goh CL, Heath CM, James ND, Kim-Sing C, Kodavatiganti R, Malone SC, Morris SL, Nabid A, Ong AD, Raman R, Rodda S, Wells P, Worlding J, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 May 16:S0140-6736(24)00549-X. doi: 10.1016/S0140-6736(24)00549-X. Online ahead of print. Lancet. 2024. PMID: 38763153 Free article.
Unraveling the Ultrafast Photochemical Dynamics of Nitrobenzene in Aqueous Solution.
Lau NA, Ghosh D, Bourne-Worster S, Kumar R, Whitaker WA, Heitland J, Davies JA, Karras G, Clark IP, Greetham GM, Worth GA, Orr-Ewing AJ, Fielding HH. Lau NA, et al. Among authors: davies ja. J Am Chem Soc. 2024 Apr 17;146(15):10407-10417. doi: 10.1021/jacs.3c13826. Epub 2024 Apr 4. J Am Chem Soc. 2024. PMID: 38572973 Free PMC article.
Structure and Function of the α-Hydroxylation Bimodule of the Mupirocin Polyketide Synthase.
Winter AJ, Khanizeman RN, Barker-Mountford AMC, Devine AJ, Wang L, Song Z, Davies JA, Race PR, Williams C, Simpson TJ, Willis CL, Crump MP. Winter AJ, et al. Among authors: davies ja. Angew Chem Weinheim Bergstr Ger. 2023 Nov 20;135(47):e202312514. doi: 10.1002/ange.202312514. Epub 2023 Oct 16. Angew Chem Weinheim Bergstr Ger. 2023. PMID: 38515435 Free PMC article.
The Concise Guide to PHARMACOLOGY 2023/24: Transporters.
Alexander SPH, Fabbro D, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA, Amarosi L, Anderson CMH, Beart PM, Broer S, Dawson PA, Gyimesi G, Hagenbuch B, Hammond JR, Hancox JC, Hershfinkel M, Inui KI, Kanai Y, Kemp S, Kunji ERS, Stewart G, Tavoulari S, Thwaites DT, Verri T. Alexander SPH, et al. Among authors: davies ja. Br J Pharmacol. 2023 Oct;180 Suppl 2:S374-S469. doi: 10.1111/bph.16182. Br J Pharmacol. 2023. PMID: 38123156 Free article.
The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors.
Alexander SPH, Fabbro D, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA, Beuve A, Brouckaert P, Bryant C, Burnett JC, Farndale RW, Friebe A, Garthwaite J, Hobbs AJ, Jarvis GE, Koesling D, Kuhn M, MacEwan D, Monie TP, Potter LR, Russwurm M, Schmidt HHHW, Stasch JP, Waldman SA. Alexander SPH, et al. Among authors: davies ja. Br J Pharmacol. 2023 Oct;180 Suppl 2:S241-S288. doi: 10.1111/bph.16180. Br J Pharmacol. 2023. PMID: 38123155
586 results